Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Profit After Tax (2016 - 2026)

Celcuity's (CELC) quarterly Profit After Tax came in at -$51.0 million in Q4 2025, down 39.07% YoY from -$83.7 million in Q4 2024, and down 16.37% on a QoQ basis from -$43.8 million in Q3 2025.

Analysis

Celcuity (CELC) Profit After Tax (2016 - 2026) Analysis & Trends

Celcuity (CELC) has 10 years of Profit After Tax data on file, last reported at -$51.0 million in Q4 2025.

  • Quarterly Profit After Tax fell 39.07% year-over-year to -$51.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$177.0 million (down 58.39% YoY) and the FY2025 annual result came in at -$177.0 million, down 58.39% from the prior year.
  • Profit After Tax retreated to -$51.0 million in Q4 2025, from -$43.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$2.8 million in Q1 2021 to a low of -$51.0 million in Q4 2025.
  • A 5-year average of -$21.1 million and a median of -$16.5 million in 2023 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2021 — Profit After Tax tumbled 537.28% — and 2022, when it rose 29.02%.
  • Tracing CELC's Profit After Tax over 5 years: stood at -$6.8 million in 2021, then plunged by 71.49% to -$11.6 million in 2022, then slumped by 62.75% to -$18.8 million in 2023, then plunged by 94.46% to -$36.7 million in 2024, then plunged by 39.07% to -$51.0 million in 2025.
  • The last three Profit After Tax figures came in at -$51.0 million (Q4 2025), -$43.8 million (Q3 2025), and -$45.3 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 Celcuity 5.25 Bn 5.25 Bn - -78.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -78.86 Mn
Dec 31, 2025 -50.97 Mn
Sep 30, 2025 -43.80 Mn
Jun 30, 2025 -45.27 Mn
Mar 31, 2025 -37.00 Mn
Dec 31, 2024 -36.65 Mn
Sep 30, 2024 -29.79 Mn
Jun 30, 2024 -23.72 Mn
Mar 31, 2024 -21.61 Mn
Dec 31, 2023 -18.85 Mn
Sep 30, 2023 -18.40 Mn
Jun 30, 2023 -14.59 Mn
Mar 31, 2023 -11.94 Mn
Dec 31, 2022 -11.58 Mn
Sep 30, 2022 -10.89 Mn
Jun 30, 2022 -9.96 Mn
Mar 31, 2022 -7.93 Mn
Dec 31, 2021 -6.75 Mn
Sep 30, 2021 -6.03 Mn
Jun 30, 2021 -14.03 Mn